mrt-2359
·Code: MRT-2359
mrt-2359: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Monte Rosa Therapeutics, Inc. (GLUE) | Phase 1/Phase 2 |
Get deeper analysis on mrt-2359
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis